Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-016040

EVP, General Counsel returned 3,825 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Howton David T · EVP, General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-28 Returned to the company : show line 1 in the form −3,825 15,746 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-04 Grant or award : show line 2 in the form Stock option (right to buy) +45,000 $145.48 2029-03-04 45,000 45,000 D
Loading xslF345X03/doc4.xml…